Prognostic biomarkers and surrogate end points in PSC-Reference-Cited by-同舟云学术

Prognostic biomarkers and surrogate end points in PSC

Published:2016-11-19 Issue:12 Volume:36 Page:1748-1751
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int

Author:

Vesterhus Mette¹²,Melum Espen¹³⁴⁵

Affiliation:

1. Norwegian PSC Research Center; Division of Surgery, Inflammatory Medicine and Transplantation; Oslo University Hospital, Rikshospitalet; Oslo Norway

2. National Centre for Ultrasound in Gastroenterology; Haukeland University Hospital; Bergen Norway

3. K.G. Jebsen Inflammation Research Centre; Institute of Clinical Medicine; University of Oslo; Oslo Norway

4. Research Institute of Internal Medicine; Division of Surgery, Inflammatory Medicine and Transplantation; Oslo University Hospital, Rikshospitalet; Oslo Norway

5. Section of Gastroenterology; Department of Transplantation Medicine; , Division of Surgery, Inflammatory Medicine and Transplantation; Oslo University Hospital; Rikshospitalet Oslo Norway

Funder

Norwegian PSC Research Center

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/liv.13216/fullpdf

Reference22 articles.

1. Primary sclerosing cholangitis;Hirschfield;Lancet,2013

2. Liver transplantation in the Nordic countries - An intention to treat and post-transplant analysis from The Nordic Liver Transplant Registry 1982-2013;Fosby;Scand J Gastroenterol,2015

3. Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis;Boonstra;Hepatology,2013

4. Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis;Broome;Gut,1996

5. Update on primary sclerosing cholangitis genetics;Henriksen;Curr Opin Gastroenterol,2014

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Circulating Macrophage Activation Markers Predict Transplant-Free Survival in Patients With Primary Sclerosing Cholangitis;Clinical and Translational Gastroenterology;2021-03

2. Bile‐Derived Organoids From Patients With Primary Sclerosing Cholangitis Recapitulate Their Inflammatory Immune Profile;Hepatology;2019-03-13